I was going to ask earlier if BARDA would be aware of MSB and have an early insight to how things are going with the trial.
i realise the trial can go either way - but in mind on the balance of my probabilities in my head I have an expectation that these results will if anything be better than the initial 12 because the recipients may be in better health before receiving them, along with the fact I read here a while ago that there seems to be further benefit in administering the cells earlier - if results are indeed tracking better than 83% then BARDA to my way of thinking may think - it’s going to be hard to beat these results with anything - with no negative side affects - next best thing is for a cure and all the focus should now be on that.
Anyway - happy holding and looking forward to our future
BARDA, Vaccines not Treatment, page-27
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |